Navigation Links
HIV/AIDS Epidemic to Cause Adverse Effects to Indian Economy

labor wages would suffer the most.

Total incomes of HIV affected households could decrease by 9.24 percent following morbidity or death due to HIV and AIDS which would lead to reduced savings and investment causing a deleterious impact on the economy as a whole.

Further loss of earnings due to leave or absence from work could have a still more negative impact on consumption and savings, leading to a whole range of second rung impacts.


'"/>




Page: 1 2

Related medicine news :

1. Optimum Timing for HIV/AIDS Prognosis
2. Estimates For Number Of HIV/AIDS Deaths In India Still Not Available
3. Testing For HIV/AIDS Compulsory For New Military Recruits
4. HIV/AIDS - May push Back the Tide of Progress in India
5. Indian Olympic Association And UNICEF To Collaborate On HIV/AIDS Awareness
6. Indian Minister wanted Media to Propaganda HIV/AIDS awareness
7. Relief for HIV/AIDS patients: ART therapy now available in India
8. Conditions Of The HIV/AIDS Patients In The Mizo Society
9. Liberia in safe hands with respect to HIV/AIDS
10. Men queue up for Circumcision In Swaziland To Prevent HIV/AIDS
11. HIV/AIDS Throws Family Relationships Out Of Gear In Uganda
Post Your Comments:
(Date:9/4/2008)... may be shortchanging their golden years by tappin...iversity of Illinois expert who has studied the fe..., More than three of every four Americans trim th...iming benefits early, a choice many might forego i... consequences, law professor Richard L. Kaplan say...
(Date:9/4/2008)...ncology contract research organization, has publis...uanced Approach to Get Into the Clinic Faster.&quo...al research scientist with 35 years of experience,...mmonly viewed as straightforward investigations ru...rue integration with preclinical, regulatory and c...
(Date:9/4/2008)...NORWICH, England and ONGAR, Ireland,Sept. 4 /PRNe...ofield Media,Europe Ltd, announced on the 29th Aug... publication from Silverdog Publishing., Health a... the iconic,Health and Safety at Work Act 1974 and.... It has been relied upon by blue-chip corporates,...
(Date:9/4/2008)...-FirstCall/ -- ULURU Inc. (Amex:,ULU) today announ...Weisel,Partners Healthcare Conference at 3:15 p.m....out ULURU Inc.:, ULURU Inc. is an emerging specia...ent of a portfolio of wound management, plastic su...nd consumers improved clinical,outcomes through co...
Breaking Medicine News(10 mins):Health News:New guide explores making the most of Social Security 2Health News:New guide explores making the most of Social Security 3Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 2Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 3Health News:Schofield Publishing Enters the Newsletter Market 2
...company announced the initial results of the three...proving the vaccine if it were 30 percent effectiv... sample of volunteers, including all racial groups...r in the study, said the study "did not show a sta...
...e born may affect your risk of schizophrenia. Rese...zophrenia associated with advanced paternal age, p... brain disorder that distorts the way a person thi...ality and relates to others. It is a life-long dis...
...ore than 2 million people worldwide and is caused ...he brain that result in seizures. More than half o...ing medications. But now a new study is under way ... compared to drug therapy when treating those with...
...n gene may make people more susceptible to depress...r a loved one. People only have to inherit one cop...vulnerable to depression, the researchers in Brita...d. Stress events, such as divorce or illness, are ...
Other Medicine News:Health News:AIDS vaccine falls short but shows some promise 2
(Date:9/4/2008)...n Schedule with Two Abstracts Accepted for Pre...mber 2008, BRIDGEWATER, N.J., Sept. 4 /PRNewswire...harmaceutical company focused on the treatment of,...ced the appointment of,Peter L. Garrambone, Jr. to...one,s career includes more than 50 pharmaceutical,...
(Date:9/3/2008)...ked. Wrong Children Studied. Wrong,Conclusions Rea... -- A Centers for Disease,Control and Prevention (...between the MMR vaccine and autism. The National A...ng to dispel the growing public concern over a,vac...s concerning design,and methodology., For years, ...
(Date:9/3/2008)...matology Research and Education Foundation,s With...in Detecting, Treating and Und...or the first time during its,unprecedented initiat...merican College of Rheumatology Research and Educa...red from research funded by the Within Our,Reach: ...
(Date:9/3/2008)...al Vascular Disease Awareness Month, CHARLOTTESVI...ceuticals,LLC, a clinical-stage drug-development c... of unmet medical needs, announced today that it h...al trial of its lead drug,candidate trans sodium c...1,on the clinicaltrials.gov Website, is investigat...
Breaking Medicine Technology:Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials 2CDC Misses Target With Flawed MMR/Autism Study 2New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 2New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 4Pelosi Floor Statement Urging Override of Presidents Veto of SCHIP 4117 1Pelosi Floor Statement Urging Override of Presidents Veto of SCHIP 4117 2Pelosi Floor Statement Urging Override of Presidents Veto of SCHIP 4117 3Pelosi Floor Statement Urging Override of Presidents Veto of SCHIP 4117 4Epeius Biotechnologies Leads With Keynote Address on the Advent of Pathotropic Medicine for Cancer at the Global Pharma R 26D Summit Conference in Bos 1359 1Epeius Biotechnologies Leads With Keynote Address on the Advent of Pathotropic Medicine for Cancer at the Global Pharma R 26D Summit Conference in Bos 1359 2Epeius Biotechnologies Leads With Keynote Address on the Advent of Pathotropic Medicine for Cancer at the Global Pharma R 26D Summit Conference in Bos 1359 3Catholic Health Association Disappointed by Failure to Override SCHIP Veto 4111 1Shand Morahan 26 Co Inc and AVRECO Launch New Risk Management Program for Midwest Hospitals 4107 1Shand Morahan 26 Co Inc and AVRECO Launch New Risk Management Program for Midwest Hospitals 4107 2
...S WIRE)--May 25, 2007 - GTx, Inc., (NASDAQ:,GTXI) ... proof of,concept clinical trial of Ostarine(TM) a...ating ACAPODENE(R) (toremifene citrate) 80,mg for ...,deprivation therapy (ADT) will be presented at th...iety of Clinical Oncology being,held June 1 - 5 at...
...)--May 29, 2007 - Pfizer said today that,results s...such as,melanoma, thyroid, liver, non-small cell l...noma (RCC) - a type of advanced kidney,cancer - wi...of,Clinical Oncology (ASCO) annual meeting in Chic...y to treatment, so,it,s critical that physicians h...
Other Medicine Technology:GTx Announces Presentation of Ostarine and Acapodene Data at 2007,ASCO Annual Meeting 2GTx Announces Presentation of Ostarine and Acapodene Data at 2007,ASCO Annual Meeting 3New Pfizer Oncology Data Across Numerous Cancer Types to be,Presented at ASCO 2New Pfizer Oncology Data Across Numerous Cancer Types to be,Presented at ASCO 3New Pfizer Oncology Data Across Numerous Cancer Types to be,Presented at ASCO 4New Pfizer Oncology Data Across Numerous Cancer Types to be,Presented at ASCO 5
Foraminotomy Kerrison Rongeurs
Synovectomy Rongeur
Fried Rongeurs
Tiemann Double Action 6" Bone Rongeur
Medicine Products: